Your browser doesn't support javascript.
loading
Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer.
Adachi, Yayoi; Oze, Isao; Sawaki, Masataka; Hattori, Masaya; Yoshimura, Akiyo; Kotani, Haruru; Kataoka, Ayumi; Sugino, Kayoko; Horisawa, Nanae; Ozaki, Yuri; Endo, Yuka; Nozawa, Kazuki; Takatsuka, Daiki; Iwata, Hiroji.
Affiliation
  • Adachi Y; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Oze I; Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Hattori M; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Yoshimura A; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Kotani H; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Kataoka A; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Sugino K; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Horisawa N; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Ozaki Y; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Endo Y; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Nozawa K; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Takatsuka D; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan.
  • Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa, Nagoya, 464-8681, Japan. hiwata@aichi-cc.jp.
Breast Cancer ; 28(5): 1087-1095, 2021 Sep.
Article de En | MEDLINE | ID: mdl-33886077
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tamoxifène / Tumeurs du sein / Traitement médicamenteux adjuvant / Antinéoplasiques hormonaux Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Middle aged Langue: En Journal: Breast Cancer Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tamoxifène / Tumeurs du sein / Traitement médicamenteux adjuvant / Antinéoplasiques hormonaux Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Middle aged Langue: En Journal: Breast Cancer Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: Japon